Zheng‐Jun Zhou

4.9k total citations · 2 hit papers
72 papers, 3.6k citations indexed

About

Zheng‐Jun Zhou is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zheng‐Jun Zhou has authored 72 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 26 papers in Oncology and 22 papers in Cancer Research. Recurrent topics in Zheng‐Jun Zhou's work include Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), MicroRNA in disease regulation (11 papers) and RNA modifications and cancer (9 papers). Zheng‐Jun Zhou is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), MicroRNA in disease regulation (11 papers) and RNA modifications and cancer (9 papers). Zheng‐Jun Zhou collaborates with scholars based in China, Ethiopia and United States. Zheng‐Jun Zhou's co-authors include Shao‐Lai Zhou, Jia Fan, Jian Zhou, Zhiqiang Hu, Zhi Dai, Xiaowu Huang, Ya Cao, Zheng Wang, Erbao Chen and Chu‐Bin Luo and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Zheng‐Jun Zhou

69 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib

2016 662 citations Shao‐Lai Zhou, Zheng‐Jun Zhou et al. profile →
Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives

2025 20 citations Jiali Yang, Rui Lai et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zheng‐Jun Zhou China	30	1.6k	1.3k	1.2k	1.2k	462	72	3.6k
Wei Yuan China	32	1.2k 0.8×	882 0.7×	912 0.8×	558 0.5×	399 0.9×	106	2.9k
Sean P. Pitroda United States	33	1.1k 0.7×	1.8k 1.3×	933 0.8×	677 0.6×	1.0k 2.2×	94	3.4k
Li Zhou China	32	1.5k 1.0×	905 0.7×	314 0.3×	1.0k 0.9×	297 0.6×	118	2.7k
Dong‐Ming Kuang China	29	943 0.6×	2.0k 1.6×	2.7k 2.2×	620 0.5×	339 0.7×	48	4.0k
Dong Gao China	27	1.7k 1.0×	1.1k 0.9×	599 0.5×	876 0.7×	964 2.1×	68	3.3k
Annemilaï Tijeras‐Raballand France	21	1.2k 0.7×	1.2k 0.9×	540 0.5×	503 0.4×	264 0.6×	47	2.2k
Oakley C. Olson United States	18	1.3k 0.8×	1.5k 1.1×	2.3k 1.9×	702 0.6×	324 0.7×	23	4.2k
Meriem Hasmim France	28	1.5k 1.0×	2.2k 1.7×	2.1k 1.8×	1.5k 1.3×	536 1.2×	42	4.6k
Jennifer L. Hsu United States	29	2.7k 1.7×	2.4k 1.8×	1.7k 1.4×	1.3k 1.1×	791 1.7×	62	5.1k
Hee Jung An South Korea	27	1.3k 0.8×	818 0.6×	286 0.2×	766 0.6×	382 0.8×	76	2.5k

Countries citing papers authored by Zheng‐Jun Zhou

Since Specialization

Citations

This map shows the geographic impact of Zheng‐Jun Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheng‐Jun Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheng‐Jun Zhou more than expected).

Fields of papers citing papers by Zheng‐Jun Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheng‐Jun Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheng‐Jun Zhou. The network helps show where Zheng‐Jun Zhou may publish in the future.

Co-authorship network of co-authors of Zheng‐Jun Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zheng‐Jun Zhou. A scholar is included among the top collaborators of Zheng‐Jun Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheng‐Jun Zhou. Zheng‐Jun Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Jiali, Rui Lai, Zheng‐Jun Zhou, et al.. (2025). Impact of lactate on immune cell function in the tumor microenvironment: mechanisms and therapeutic perspectives. Frontiers in Immunology. 16. 1563303–1563303. 20 indexed citations breakdown →

Zhou, Zheng‐Jun, Zhiqiang Hu, Yayi Hou, et al.. (2024). Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver. Nature Communications. 15(1). 9960–9960. 4 indexed citations

Zheng, Haowen, Rui Lai, Zheng‐Jun Zhou, et al.. (2024). Comprehensive Management of Intracranial Aneurysms Using Artificial Intelligence: An Overview. World Neurosurgery. 193. 209–221. 4 indexed citations

Ling, Chen, Cong Wang, Yun He, et al.. (2024). rAAV capsid mutants eliminate leaky expression from DNA donor template for homologous recombination. Nucleic Acids Research. 52(11). 6518–6531. 6 indexed citations

Hu, Zhiqiang, Songyang Yu, Hezhi Wang, et al.. (2024). A novel protein encoded by circFOXP1 enhances ferroptosis and inhibits tumor recurrence in intrahepatic cholangiocarcinoma. Cancer Letters. 598. 217092–217092. 13 indexed citations

Pan, Si-Yuan, et al.. (2024). Mutation-based therapies for intrahepatic cholangiocarcinoma: new options on the horizon. Hepatoma Research. 1 indexed citations

Yu, Songyang, Peng‐Cheng Wang, Jia Li, et al.. (2024). Tumor-associated macrophage-induced circMRCKα encodes a peptide to promote glycolysis and progression in hepatocellular carcinoma. Cancer Letters. 591. 216872–216872. 11 indexed citations

Sun, Rongqi, Ye Xu, Bo Wang, et al.. (2024). Integrated molecular characterization of sarcomatoid hepatocellular carcinoma. Clinical and Molecular Hepatology. 31(2). 426–444. 2 indexed citations

Xin, Haoyang, Ning Li, Si-Yuan Pan, et al.. (2024). Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma. Clinical and Molecular Hepatology. 30(4). 914–928. 1 indexed citations

10.

Xin, Haoyang, Rongqi Sun, Pengcheng Wang, et al.. (2023). Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma. JAMA Network Open. 6(3). e231476–e231476. 22 indexed citations

11.

Li, Jia, Zhiqiang Hu, Songyang Yu, et al.. (2022). CircRPN2 Inhibits Aerobic Glycolysis and Metastasis in Hepatocellular Carcinoma. Cancer Research. 82(6). 1055–1069. 100 indexed citations

12.

Zhou, Shao‐Lai, Zheng‐Jun Zhou, Chengli Song, et al.. (2022). Whole-genome sequencing reveals the evolutionary trajectory of HBV-related hepatocellular carcinoma early recurrence. Signal Transduction and Targeted Therapy. 7(1). 24–24. 22 indexed citations

13.

Zhou, Zheng‐Jun, Guangshun Chen, Zhiyong He, et al.. (2022). Risk Factors of Early Allograft Dysfunction in Patients With Hepatitis B Virus-Related Acute-on-Chronic Liver Failure After Deceased Donor Liver Transplant. Experimental and Clinical Transplantation. 20(7). 668–673. 2 indexed citations

14.

Zhu, Guiqi, Yi Wang, Wei‐Ren Liu, et al.. (2022). Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology. 13(5). 1413–1447. 29 indexed citations

15.

Hu, Zhiqiang, Haoyang Xin, Chu‐Bin Luo, et al.. (2020). Associations among the mutational landscape, immune microenvironment, and prognosis in Chinese patients with hepatocellular carcinoma. Cancer Immunology Immunotherapy. 70(2). 377–389. 31 indexed citations

16.

Hu, Zhiqiang, Zheng‐Jun Zhou, Chu‐Bin Luo, et al.. (2020). Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection. Cancer Cell International. 20(1). 582–582. 20 indexed citations

17.

Zhou, Zheng‐Jun, Chu‐Bin Luo, Haoyang Xin, et al.. (2020). MACROD2 deficiency promotes hepatocellular carcinoma growth and metastasis by activating GSK-3β/β-catenin signaling. npj Genomic Medicine. 5(1). 15–15. 14 indexed citations

18.

Zhu, Gui‐Qi, Yi Yang, Erbao Chen, et al.. (2019). Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients. Journal of Translational Medicine. 17(1). 203–203. 16 indexed citations

19.

Zhu, Guiqi, Kang Wang, Yujie Zhou, et al.. (2018). Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization. Cancer Management and Research. Volume 11. 63–79. 12 indexed citations

20.

Zhou, Zheng‐Jun, Zhi Dai, Shao‐Lai Zhou, et al.. (2014). HNRNPAB Induces Epithelial–Mesenchymal Transition and Promotes Metastasis of Hepatocellular Carcinoma by Transcriptionally Activating SNAIL. Cancer Research. 74(10). 2750–2762. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact